DreamCIS, Inc.
Research DreamCIS, Inc. (223250.KQ) on Bullrun: market cap KRW 95.08B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker223250.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryMedical Care Facilities
- CurrencyKRW
- Market capKRW 95.08B
- Financial periodQ2 2026
- RevenueKRW 20.01B
- Net income-KRW 4.35B
- Free cash flow-KRW 2.98B
- Gross margin30.4%
Valuation Snapshot
latest market cap is KRW 95.08B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 95.08B | n/a | n/a | n/a |
Dividend history
About DreamCIS, Inc.
DreamCIS, Inc. operates as a clinical research organization in South Korea, Europe, China, Asia Pacific, the United States, and Canada. It offers clinical development services; standalone services, including biostatics, data and project management, pharmacovigilance, medical writing, site start up, clinical monitoring, Dreamtrial, IWRS, and quality assurance services; medical device development services; and consulting services. The company was founded in 2000 and is headquartered in Seoul, South Korea.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is DreamCIS, Inc.'s market cap?
DreamCIS, Inc.'s market capitalization is KRW 95.08B.
What does DreamCIS, Inc. do?
DreamCIS, Inc. operates as a clinical research organization in South Korea, Europe, China, Asia Pacific, the United States, and Canada. It offers clinical development services; standalone services, including biostatics, data and project management, pharmacovigilance, medical writing, site start up, clinical monitoring, Dreamtrial, IWRS, and quality assurance services; medical device development services; and consulting services. The company was founded in 2000 and is headquartered in Seoul, South Korea. DreamCIS, Inc. operates as a subsidiary of Hangzhou Tigermed Consulting Co., Ltd.